2025 Q3 -tulosraportti
Vain PDF
61 päivää sitten
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
2 050
Myynti
Määrä
28 858
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 469 | - | - | ||
| 1 600 | - | - | ||
| 3 624 | - | - | ||
| 1 376 | - | - | ||
| 45 000 | - | - |
Ylin
0,32VWAP
Alin
0,31VaihtoMäärä
0,2 743 226
VWAP
Ylin
0,32Alin
0,31VaihtoMäärä
0,2 743 226
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 757 437 | 757 437 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 757 437 | 757 437 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenI choose, as I usually do with this type of issues, to sell all shares, even if it is loss-making, and use the money to buy new ones in the issue. This way I support the issue and contribute to fewer shares being sold to underwriters with further discount and dilution of other shareholders. And since the existing share is still more expensive than the new shares, I also get a few more shares for the same price. So, even with a loss, it's a pure win-win that way, if one wants to stay in the share. The official NAV discount at a price of 0,335 SEK is approx. 92 % (ibindex.se). After a fully subscribed issue, it will fall to approx. 77 % at an expected price of 0,30 SEK. (Temporarily, the price can of course become lower right after the issue, as is unfortunately often seen when the underwriters sell off the new shares they bought at a large discount compared to us other shareholders.) However, I am more interested in what I call the real NAV discount. I assume that the share price is 0,30 SEK, that the issue is fully subscribed and adds 203 mio. SEK minus 17. mio., SEK in costs. Under these assumptions, the buyers of the newly issued shares get the entire holding of unlisted shares quite free – or almost free. More precisely, the real NAV discount under these assumptions becomes 99 %. I calculate the real NAV discount exclusively in relation to the unlisted shares, by first fully offsetting the value of the listed shares (there is only a very small listed share left currently) as well as positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value of the unlisted shares is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes supplement further. But now that the entire pool of unlisted shares is free, much uncertainty can be priced in. Secondly, one must consider the security in relation to how much individual shares fill in the portfolio. In this share, Umecrine alone accounts for almost 55 % of the unlisted shares, which some believe is the background for the large NAV discount in this company. But the large NAV discount more than sufficiently accounts for it, if Umecrine unexpectedly were to be worth 0 kr. So that does not worry me. Even if all 3 largest companies were to go bankrupt, the share's NAV would still be intact in relation to the price.
·1 päivä sittenwhat is your stance on the new share issue?4 ääntä 1 päivä 1 tunti jäljelläLiity Sharevilleen osallistuaksesi kyselyyn
·7.1.This company is heading straight down into the abyss. Who is responsible for this?·8.1. · MuokattuYes, sorry that Shareville has developed in that direction. But you can "mute" the people you can't stand, and find some nuggets by reading back on most pages - also on this page. The Novo page and certain others one can probably well avoid spending time on p.t..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
61 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenI choose, as I usually do with this type of issues, to sell all shares, even if it is loss-making, and use the money to buy new ones in the issue. This way I support the issue and contribute to fewer shares being sold to underwriters with further discount and dilution of other shareholders. And since the existing share is still more expensive than the new shares, I also get a few more shares for the same price. So, even with a loss, it's a pure win-win that way, if one wants to stay in the share. The official NAV discount at a price of 0,335 SEK is approx. 92 % (ibindex.se). After a fully subscribed issue, it will fall to approx. 77 % at an expected price of 0,30 SEK. (Temporarily, the price can of course become lower right after the issue, as is unfortunately often seen when the underwriters sell off the new shares they bought at a large discount compared to us other shareholders.) However, I am more interested in what I call the real NAV discount. I assume that the share price is 0,30 SEK, that the issue is fully subscribed and adds 203 mio. SEK minus 17. mio., SEK in costs. Under these assumptions, the buyers of the newly issued shares get the entire holding of unlisted shares quite free – or almost free. More precisely, the real NAV discount under these assumptions becomes 99 %. I calculate the real NAV discount exclusively in relation to the unlisted shares, by first fully offsetting the value of the listed shares (there is only a very small listed share left currently) as well as positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value of the unlisted shares is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes supplement further. But now that the entire pool of unlisted shares is free, much uncertainty can be priced in. Secondly, one must consider the security in relation to how much individual shares fill in the portfolio. In this share, Umecrine alone accounts for almost 55 % of the unlisted shares, which some believe is the background for the large NAV discount in this company. But the large NAV discount more than sufficiently accounts for it, if Umecrine unexpectedly were to be worth 0 kr. So that does not worry me. Even if all 3 largest companies were to go bankrupt, the share's NAV would still be intact in relation to the price.
- ·1 päivä sittenwhat is your stance on the new share issue?4 ääntä 1 päivä 1 tunti jäljelläLiity Sharevilleen osallistuaksesi kyselyyn
- ·7.1.This company is heading straight down into the abyss. Who is responsible for this?·8.1. · MuokattuYes, sorry that Shareville has developed in that direction. But you can "mute" the people you can't stand, and find some nuggets by reading back on most pages - also on this page. The Novo page and certain others one can probably well avoid spending time on p.t..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
2 050
Myynti
Määrä
28 858
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 469 | - | - | ||
| 1 600 | - | - | ||
| 3 624 | - | - | ||
| 1 376 | - | - | ||
| 45 000 | - | - |
Ylin
0,32VWAP
Alin
0,31VaihtoMäärä
0,2 743 226
VWAP
Ylin
0,32Alin
0,31VaihtoMäärä
0,2 743 226
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 757 437 | 757 437 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 757 437 | 757 437 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
61 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 13.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 14.11.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 14.2.2025 | |
| 2024 Q3 -tulosraportti | 15.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenI choose, as I usually do with this type of issues, to sell all shares, even if it is loss-making, and use the money to buy new ones in the issue. This way I support the issue and contribute to fewer shares being sold to underwriters with further discount and dilution of other shareholders. And since the existing share is still more expensive than the new shares, I also get a few more shares for the same price. So, even with a loss, it's a pure win-win that way, if one wants to stay in the share. The official NAV discount at a price of 0,335 SEK is approx. 92 % (ibindex.se). After a fully subscribed issue, it will fall to approx. 77 % at an expected price of 0,30 SEK. (Temporarily, the price can of course become lower right after the issue, as is unfortunately often seen when the underwriters sell off the new shares they bought at a large discount compared to us other shareholders.) However, I am more interested in what I call the real NAV discount. I assume that the share price is 0,30 SEK, that the issue is fully subscribed and adds 203 mio. SEK minus 17. mio., SEK in costs. Under these assumptions, the buyers of the newly issued shares get the entire holding of unlisted shares quite free – or almost free. More precisely, the real NAV discount under these assumptions becomes 99 %. I calculate the real NAV discount exclusively in relation to the unlisted shares, by first fully offsetting the value of the listed shares (there is only a very small listed share left currently) as well as positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value of the unlisted shares is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes supplement further. But now that the entire pool of unlisted shares is free, much uncertainty can be priced in. Secondly, one must consider the security in relation to how much individual shares fill in the portfolio. In this share, Umecrine alone accounts for almost 55 % of the unlisted shares, which some believe is the background for the large NAV discount in this company. But the large NAV discount more than sufficiently accounts for it, if Umecrine unexpectedly were to be worth 0 kr. So that does not worry me. Even if all 3 largest companies were to go bankrupt, the share's NAV would still be intact in relation to the price.
- ·1 päivä sittenwhat is your stance on the new share issue?4 ääntä 1 päivä 1 tunti jäljelläLiity Sharevilleen osallistuaksesi kyselyyn
- ·7.1.This company is heading straight down into the abyss. Who is responsible for this?·8.1. · MuokattuYes, sorry that Shareville has developed in that direction. But you can "mute" the people you can't stand, and find some nuggets by reading back on most pages - also on this page. The Novo page and certain others one can probably well avoid spending time on p.t..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
2 050
Myynti
Määrä
28 858
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 469 | - | - | ||
| 1 600 | - | - | ||
| 3 624 | - | - | ||
| 1 376 | - | - | ||
| 45 000 | - | - |
Ylin
0,32VWAP
Alin
0,31VaihtoMäärä
0,2 743 226
VWAP
Ylin
0,32Alin
0,31VaihtoMäärä
0,2 743 226
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 757 437 | 757 437 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 757 437 | 757 437 | 0 | 0 |